TipRanks
Pharming Group (DE:PHGN)
XETRA:PHGN
Germany Market
PHGN
Pharming Group
RESEARCH TOOLSreports

Pharming Group (PHGN) Income Statement

5 Followers

Pharming Group Income Statement

Last quarter (Q2 2026), Pharming Group's total revenue was €90.21M, a decrease of -3.23% from the same quarter last year. In Q2, Pharming Group's net income was €1.64M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 376.13M$ 297.07M$ 245.32M$ 205.62M$ 198.87M
Gross Profit
$ 330.63M$ 261.80M$ 220.10M$ 188.06M$ 165.73M
Operating Expenses
$ 309.75M$ 265.47M$ 242.39M$ 169.83M$ 163.52M
Depreciation and Amortization
$ 11.22M$ 10.57M$ 15.93M$ 13.19M$ 22.23M
EBITDA
$ 34.78M$ 13.65M$ 9.88M$ 33.53M$ 55.30M
Operating Income
$ 20.88M$ -3.67M$ -4.88M$ 18.23M$ 19.01M
Other Income/Expenses
$ -8.03M$ -4.83M$ -7.13M$ -3.25M$ 4.07M
Pretax Income
$ 12.85M$ -8.49M$ -12.01M$ 14.99M$ 23.08M
Net Income
$ 2.97M$ -11.84M$ -10.55M$ 13.67M$ 15.34M
Per Share Metrics
Basic EPS
$ <0.01$ -0.02$ -0.01$ 0.02$ 0.02
Diluted EPS
$ <0.01$ -0.02$ -0.01$ 0.02$ 0.02
Weighted Average Shares Outstanding
 721.77M 689.19M 821.28M 883.93M 876.44M
Weighted Average Shares Outstanding (Diluted)
 721.77M 689.19M 843.25M 883.93M 876.44M

Pharming Group Earnings and Revenue History